Resultados de búsqueda

Selective immunomodulation by the antineoplastic agent mitoxantrone. II. Nonspecific adherent suppressor cells derived from mitoxantrone-treated mice. por John M. Fidler, Susan Quinn DeJoy, F R Smith, J J Gibbons

Enlace del recurso Enlace del recurso

Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of BCL-2 and BAX. por David J. McConkey, Joya Chandra, Susan Wright, William Plunkett, Timothy J. McDonnell, John C. Reed, M Keating

Enlace del recurso Enlace del recurso

Results of a randomized trial in children with Acute Myeloid Leukaemia: Medical Research Council AML12 trial por Brenda Gibson, David Webb, Andrew Howman, Siebold S.N. de Graaf, Christine J. Harrison, Keith Wheatley

Enlace del recurso Enlace del recurso

Favorable prognosis of hyperdiploid common acute lymphoblastic leukemia may be explained by sensitivity to antimetabolites and other drugs: results of an in vitro study por Gertjan J.L. Kaspers, LA Smets, Rob Pieters, CH Van Zantwijk, ER van Wering, A. Veerman

Enlace del recurso

Dimethyl fumarate for multiple sclerosis por Xu Zhu, Feng Zhang, Fangli Sun, KeFeng Gu, Shuai Dong, Dian He

Enlace del recurso

In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia por E. Klumper, Rob Pieters, A. Veerman, DR Huismans, AH Loonen, K. Hählen, Gertjan J.L. Kaspers, ER van Wering, R. Hartmann, G. Henze

Enlace del recurso Enlace del recurso

Granulocyte Colony-Stimulating Factor (Filgrastim) Accelerates Granulocyte Recovery After Intensive Postremission Chemotherapy for Acute Myeloid Leukemia With Aziridinyl Benzoquino... por Joseph O. Moore, Richard K. Dodge, Philip C. Amrein, Jonathan E. Kolitz, Edward J. Lee, Bayard L. Powell, Godfrey Scott, Francisco Robert, Charles A. Schiffer

Enlace del recurso Enlace del recurso

First‐ and second‐line chemotherapy with docetaxel or mitoxantrone in patients with hormone‐refractory prostate cancer por Jorg Michels, Trina Montemurro, Nevin Murray, Christian Kollmannsberger, Kim Nguyen

Enlace del recurso Enlace del recurso

Hedgehog Pathway Inhibitor HhAntag691 Is a Potent Inhibitor of ABCG2/BCRP and ABCB1/Pgp por Yimao Zhang, John Laterra, Martin G. Pomper

Enlace del recurso

Requirement for safety monitoring for approved multiple sclerosis therapies: an overview por Paulus Rommer, Uwe K. Zettl, B. C. Kieseier, H-P Hartung, Til Menge, E. Frohman, Benjamin Greenberg, Bernhard Hemmer, Olaf Stüve

Enlace del recurso

Cladribine combined with high doses of arabinoside cytosine, mitoxantrone, and G‐CSF (CLAG‐M) is a highly effective salvage regimen in patients with refractory and relapsed acute m... por Agnieszka Wierzbowska, Tadeusz Robak, Agnieszka Pluta, Ewa Wawrzyniak, Barbara Cebula‐Obrzut, Jerzy Hołowiecki, Sławomira Kyrcz‐Krzemień, Sebastian Grosicki, Sebastian Giebel, Aleksander B. Skotnicki, Beata Piątkowska‐Jakubas, Kazimierz Kuliczkowski, Marek Kiełbiński, Krystyna Zawilska, Janusz Kłoczko, Agata Wrzesień‐Kuś

Enlace del recurso Enlace del recurso

The multidrug transporter ABCG2 (BCRP) is inhibited by plant‐derived cannabinoids por Michelle L. Holland, Diana Lau, John Allen, Jonathon C. Arnold

Enlace del recurso

Autologous Bone Marrow Transplantation for Acute Promyelocytic Leukemia in Second Remission: Prognostic Relevance of Pretransplant Minimal Residual Disease Assessment by Reverse-Tr... por Giovanna Meloni, Daniela Diverio, Marco Vignetti, Giuseppe Avvisati, Saveria Capria, Maria Concetta Petti, Franco Mandelli, Francesco Lo‐Coco

Enlace del recurso Enlace del recurso

High-dose cytosine arabinoside and mitoxantrone: a highly effective regimen in refractory acute myeloid leukemia por Wolfgang Hiddemann, H. Kreutzmann, Kurt Straíf, WD Ludwig, R Mertelsmann, R Donhuijsen- Ant, Eva Lengfelder, Z Arlin, T Buchner

Enlace del recurso Enlace del recurso

Selective immunomodulation by the antineoplastic agent mitoxantrone. I. Suppression of B lymphocyte function. por John M. Fidler, Susan Quinn DeJoy, J J Gibbons

Enlace del recurso Enlace del recurso

Treatment of newly diagnosed acute myelogenous leukemia with granulocyte-macrophage colony-stimulating factor (GM-CSF) before and during continuous-infusion high-dose ara-C + dauno... por Elihu H. Estey, P. Thall, Hagop M. Kantarjian, Susan O’Brien, CA Koller, Miloslav Beran, Jordan U. Gutterman, A. B. Deisseroth, Michael J. Keating

Enlace del recurso

Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy por Jonathan Pol, Erika Vacchelli, Fernando Aranda, Francesca Castoldi, Alexander Eggermont, Isabelle Cremer, Catherine Sautès‐Fridman, Jitka Fučíková, Jérôme Galon, Radek Špíšek, Éric Tartour, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi

Enlace del recurso Enlace del recurso

Hormone Refractory Prostate Cancer (Hrpc): Present and Future Approaches of Therapy por Giuseppe Di Lorenzo, Sabino De Placido

Enlace del recurso Enlace del recurso

DNA damage induces GDNF secretion in the tumor microenvironment with paracrine effects promoting prostate cancer treatment resistance por Roland M. Huber, Jared M. Lucas, Luis Gomez-Sarosi, Ilsa M. Coleman, Song Zhao, Roger Coleman, Peter S. Nelson

Enlace del recurso Enlace del recurso

Mitoxantrone for multiple sclerosis por Filippo Martinelli Boneschi, Laura Vacchi, Marco Rovaris, Ruggero Capra, Giancarlo Comi

Enlace del recurso